Related Experiment Video
Updated: Feb 6, 2026

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
PRSS8 suppresses colorectal carcinogenesis and metastasis
Yonghua Bao1, Yongchen Guo1, Yiqiong Yang1
1Department of Pathology and Institute of Precision Medicine, Jining Medical University, Jining, 272067, China.
The serine protease PRSS8 acts as a tumor suppressor, inhibiting colorectal cancer initiation and metastasis. Its deficiency leads to colitis and intestinal tumors, while its presence suppresses cancer growth.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The serine protease PRSS8 (Prostasin) has known physiological roles, but its specific involvement in cancer development remains largely undefined.
- Understanding PRSS8's function is crucial for identifying new therapeutic targets in cancer treatment.
Purpose of the Study:
- To investigate the role of PRSS8 in colorectal cancer initiation, progression, and metastasis.
- To elucidate the molecular mechanisms underlying PRSS8's function in the context of cancer.
Main Methods:
- Development and characterization of a conditional knockout Prss8 mouse model (Prss8fl/fl, p-Villin-Cre+).
- In vivo studies using nude mice to assess cancer cell growth and metastasis.
- In vitro assays including migration, invasion, colony formation, and tumor sphere formation.
- Gene profiling, gene set enrichment analysis, TCGA data mining, and immunohistochemical staining.
Main Results:
- Prss8 gene deficiency in mice resulted in spontaneous colitis, rectal inflammation, and later development of intestinal tumors, associated with altered cell proliferation, migration, and differentiation.
- Increased PRSS8 expression suppressed cancer cell growth, metastasis, migration, invasion, and colony formation in vitro and in vivo.
- Decreased PRSS8 expression promoted malignancies in both experimental settings.
- Mechanistic studies indicated that PRSS8 targets the Wnt/β-catenin, epithelial-mesenchymal transition, and stem cell signaling pathways.
Conclusions:
- PRSS8 functions as a novel tumor suppressor in the context of colorectal cancer.
- PRSS8 plays a critical role in suppressing colorectal carcinogenesis and metastasis by modulating key signaling pathways.
More Related Videos
11:43Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Hypothalamic-Pituitary Axis